n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, April 21st, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Horizon Minerals Corp. (HZNM)

Insider Financial, Bloomberg, Reuters, MarketWatch, and Marketwired reported on Horizon Minerals Corp. (HZNM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in Delaware on May 11, 2011, Horizon Minerals Corp. previously engaged in mining gold and other precious metals. It formerly went by the name Safe Dynamics Corp. It changed its corporate name to Horizon Minerals Corp. in March 2013. A development stage corporation, Horizon Minerals is based in Las Vegas, Nevada. The Company lists on the OTC Markets Group’s OTCQB.

In August of 2016, Horizon Minerals announced that it engaged Gold Exploration Management, Inc.  Gold Exploration is a private corporation controlled by Mr. David A. Bending, M.Sc., P. Geo., providing mineral exploration project management services. Gold Exploration has been actively involved in the evaluation of Gold and Lithium exploration concessions in the States of Nevada, California, and Mexico.

Gold Exploration will be instrumental in helping Horizon Minerals to acquire potential projects. Horizon Minerals has a portfolio of lithium exploration projects managed by the Company's Director, Mr. Bending.

Pertaining to Horizon Minerals’ SSE Project, the properties are associated with published lithium concentrations of economic interest in brines and clays. The Company’s SSE Project is part of its Great Basin lithium portfolio that includes important assets in California, Nevada, and Utah.

In early March of this year, Horizon Minerals announced the completion of its technical report prepared in accordance with National Instrument 43-101 (NI 43-101) on the Company's SFE lithium project in the State of Nevada. The Report was completed by Mr. Robert A. Lunceford, who is a Certified Professional Geologist with the American Institute of Professional Geologists (AIPG #6456).

Mr. Lunceford is also an active Qualified Person (QP) under NI 43-101. He holds a Bachelor of Science Degree in Geology from San Diego State University (1971), as well as a Master of Science Degree in Geology from Montana State University (1976).

In essence, Horizon Minerals owns domestic lithium assets. The Company is actively acquiring more with the aim of filling some of the nation’s fast growing demand for lithium.

Horizon Minerals Corp. (HZNM), closed Friday's trading session at $0.67, even for the day, on 18,942 volume with 6 trades. The average volume for the last 60 days is 135,181 and the stock's 52-week low/high is $0.05/$1.67.

The Pulse Beverage Corporation (PLSB)

Wall Street Resources, RedChip, Marketbeat, Greenbackers, Microcap MarketPlace, Wall St Insider Stocks, Ceocast News, SmallCap Network, FreeRealTime, The Green Baron, PennyStocksV2, BestStocksDaily, HoleinOneStocks.net, and PennyStockClub reported on The Pulse Beverage Corporation (PLSB), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

The Pulse Beverage Corporation is the maker of Natural Cabana® Lemonades, Limeades, and Coconut Waters. Pulse introduced Natural Cabana® Lemonade in 2012. Since that time, it has developed a multi-national distribution system through more than 155 distributors in 49 U.S. States, Canada, Mexico, Panama, Bermuda, and Ireland. OTCQB-listed, The Pulse Beverage Corporation has its headquarters in Northglenn, Colorado.

Pulse’s aim is to be one of the market leaders in the development and marketing of nutritional/functional beverage products that provide real health benefits to a large portion of the population and are convenient and appealing to consumers. Pulse Beverage offers Natural Cabana® Lemonade/Limeade in seven, low-calorie flavors. Additionally, the Company offers Natural Cabana® Coconut Water in pineapple and natural flavors.

Pulse Beverage’s business model uses warehouse direct and key accounts. The Company has secured greater than 20,000 listings for its Lemonades and Limeades and in excess of 5,000 listings for its Coconut Waters with regional and national grocery and convenience chain stores.

Pulse Beverage teams up with major retailers. These include Walmart, Albertsons/Safeway, Kroger, Stater Bros, Food Max, Houchens, Kmart, 7-Eleven, United C-stores, and Weis Markets. Major retailers also include King Kullen, Dierbergs Markets, Hy-Vee Supermarket, WinCo Foods, Price Less Markets, Gristede's Foods, Toot n Totem, and Travel America.

Furthermore, Pulse has its PULSE Heart & Body Health product. This is a functional beverage line-up. PULSE Heart & Body Health is a natural beverage product, which is high in antioxidants, selenium, Vitamin C, and soluble fiber. This product is bottled without preservatives. PULSE Heart & Body Health comes in a 500-ml glass bottle package. The product line-up consists of three naturally sweetened flavors - Pomegranate/Blackberry, Pear/Peach, and Strawberry/Grapefruit.  

Last week, Pulse Beverage announced that it secured additional capital to meet growing demand for its products. These products include Natural Cabana® Coconut Water in Natural and Pineapple flavors, as well as Natural Cabana® Lemonades/Limeades in its newly introduced 16.9 oz. European designed bottles. As part of its reorganization and streamlining plan, it was able to attain addition capital to meet increasing product orders through June 2017.

The Pulse Beverage Corporation (PLSB), closed Friday's trading session at $0.0053, even for the day, on 14,208,132 volume with 83 trades. The average volume for the last 60 days is 10,523,625 and the stock's 52-week low/high is $0.0039/$0.20.

CVR Medical Corp. (CRRVF)

OTC Markets and MarketWatch reported on CVR Medical Corp. (CRRVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CVR Medical Corp. is engaged in an equal part joint venture (JV) with CVR Global, Inc. This JV operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology. A medical technology enterprise, CVR Medical is based in Vancouver, British Columbia.

The JV has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. The Carotid Stenotic Scan (CSS) is an inventive tool that will be used to assess Carotid Arterial health in a manner that is unavailable to the patient, healthcare provider, and the payor within the current system.

The CSS is a screening tool designed to detect and measure carotid arterial stenosis or occlusion for the purpose of identifying patients at risk for Ischemic Stroke.  The CSS provides a synergistic tool, which complements other stroke screening technology. This screening device is non-emissive and non-invasive. It does not require a certified technician and can be conducted in a few minutes.

The CSS has a per scan price point that is substantially advantageous as an initial screening tool in comparison to the resource requirement associated with other technologies. CVR’s technology makes a connection between fluid flow and sub-sonic frequencies to determine the presence of arterial disease/blockage. 

CVR Medical is entering the Clinical phase of the development process. The final market version of the CSS is undergoing assembly and preparation for Pivotal Trials that will then undergo submission for Food and Drug Administration (FDA) 510(k) clearance.

Last month, CVR Medical reported that it entered into a letter of intent (LOI) with CVR Global, Inc. to acquire an additional 10 percent interest of the "Joint Venture Business" from CVR Global's present 50 percent interest. The Joint Venture Business is held pursuant to, and governed by, the terms of the Joint Venture Agreement between CVR Global and CVR Medical. Upon the closing of the Transaction, the Joint Venture Business and related assets will be transferred into a new corporate entity to be created for the continuing ownership and operation of the business.

Furthermore, in March, CVR Medical announced a partnership with ADCO Circuits. ADCO will be the exclusive provider of the custom circuit board inside the sensor of CVR Medical's "Carotid Stenotic Scan (CSS)" device. ADCO Circuits is a Michigan-based electronic design and manufacturing enterprise.

Yesterday, CVR Medical reported that it closed the first tranche of its earlier announced non-brokered private placement financing. An aggregate of 7,521,768 units at a price of $0.48 per Unit were issued in the First Tranche for gross proceeds of $3.6 million. Currently, CVR expects to close a second and final tranche of the Financing for gross proceeds of about $600,000 on or about April 21, 2017. Net proceeds from the Financing will be used by CVR Medical for working capital in respect of its JV with CVR Global.

CVR Medical Corp. (CRRVF), closed Friday's trading session at $0.38825, up 1.64%, on 23,173 volume with 16 trades. The average volume for the last 60 days is 169,605 and the stock's 52-week low/high is $0.23/$0.5677.

Emerald Medical Applications Corp. (MRLA)

We are reporting on Emerald Medical Applications Corp. (MRLA), here at the QualityStocks Daily Newsletter.

Emerald Medical Applications Corp. is a medical technology company listed on the OTC Markets Group’s OTCQB. The Company uses proprietary military image processing technology and state-of-the-art data analytics to improve the analysis of medical images. Emerald involves in the development and sale of DermaCompare™. This is its proprietary artificial intelligence (AI) technology and application for the early diagnosis of melanoma and other skin cancers. Emerald Medical Applications has its corporate headquarters in Petach Tikva, Israel.

DermaCompare is the first application of the Company’s technology and innovation. Emerald’s technology uses the knowledge of military image processing and big data analytics to improve the analysis of medical images for the benefit of patients and the medical community.

DermaCompare is a Food and Drug Administration (FDA) Class #1 approved, HIPPA-compliant, skin cancer (melanoma) screening platform. It enables home use by using every smartphone. It applies AI and predictive analytics and maps the ‘Melanoma Starting Point’. DermaCompare is a ground-breaking skin cancer screening platform. It enables physicians to identify and monitor changes in their patients’ skin characteristics.

DermaCompare provides actionable pieces of information, higher quality with lower costs, and is aligned with population health management initiatives taken by governments internationally. DermaCompare enables patients to self-conduct a dermatology scan utilizing Total Body Photography Imaging (TBP) taken with a digital camera, usually a tablet or Smartphone (iPhone or Android). The App and instructions can be downloaded on almost any device with a digital camera.

Upon a patient uploading their TBP images to their file in the DermaCompare cloud for storage and review, the DermaCompare platform compares those images to any earlier patient images on file, and also any relevant images from Emerald’s database. Additionally, the DermaCompare platform updates the patient file and creates a summary of data points with current, relevant data regarding the patient's skin images together with alerts to any suspicious image changes.  Also, the DermaCompare platform notifies the associated physician to retrieve and review the patient's chart and TPB images.

Last month, Emerald Medical Applications announced that Publicis Groupe completed the purchase of 1,315,563 shares of the Company’s common stock. This represents a total investment of $526,225.20, based upon the agreed purchase price of $0.40 per share.

Publicis Groupe's investment in Emerald was made after considerable due diligence concerning the Company and its DermaCompare™ skin cancer screening application. Publicis Groupe's investment was the result of Emerald Medical Applications being awarded the Grand Prize of 500,000 Euros over 3,500 other competing technology companies at Publicis Groupe's "Publicis 90" Initiative at the Viva Technology event held in Paris, France, in early July of 2016. after being chosen.

Emerald Medical Applications Corp. (MRLA), closed Friday's trading session at $0.175, down 20.45%, on 263,710 volume with 66 trades. The average volume for the last 60 days is 49,847 and the stock's 52-week low/high is $0.07/$1.00.

DXI Energy, Inc. (DXIEF)

Marketwired reported previously on DXI Energy, Inc. (DXIEF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

DXI Energy, Inc. is a tactical acquisitor and developer of strategic energy resources. The Company is an upstream oil and gas exploration and production enterprise. DXI Energy operates in Colorado’s Piceance Basin and in the Peace River Arch region in British Columbia (B.C.). DXI Energy has offices in Calgary, Alberta, and Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

In Colorado's Piceance Basin DXI Energy has 25,684 net acres. In the Peace River Arch area in British Columbia it has14,444 net acres. Regarding its project areas, in the Piceance Basin in northwest Colorado, DXI Energy has its Kokopelli project with 12 producing wells with extensive in place infrastructure to supplement future development as product prices dictate.

Its land holdings in the Piceance Basin highlight potential long-term regional resource value. This is as utilities develop sources of natural gas. For Kokopelli, DXI Energy retains a 25 percent Working Interest (WI) in 2200 acres (550 net, 2 leases).

Additionally, the Company has its Roan Creek project (West Piceance Hi-Pressure Mancos/Niobrara Gas). This project is 1960 net acres, 100 percent WI, with potential
development of 8-10 high pressure Mancos/Niobrara 8200’ vertical/Hz wells.

Concerning the Piceance Basin in Colorado, it is more than 100 miles long. It has an average width of over 60 miles, covering an area of greater than 7,100 square miles. It contains reserves of coal, natural gas, as well as oil shale.

Moreover, the Woodrush Project in northeastern B.C. encompasses the above-mentioned 14,444 net acres (20,732 gross) with 14 wells (3 oil and gas, 10 natural gas and one injector). DXI Energy is the operator. The Company owns 99 percent of the Project, which is now producing 315 BOEPD (30 percent oil).

DXI Energy has a multi-phase plan to expand production and landholdings at the Woodrush Project. It is implementing a remedial program at Woodrush designed to improve daily oil production to the 200 BOPD range. The Company has $13mm invested in production facilities and a related network of pipelines at the Woodrush Project. The DXI Energy Peace River Arch projects are recognized by the conventional industry as having a history of high quality reserves. They continue to be a very competitive area.

DXI Energy, Inc. (DXIEF), closed Friday's trading session at $0.0566, up 27.77%, on 25,762 volume with 12 trades. The average volume for the last 60 days is 27,991 and the stock's 52-week low/high is $0.032/$0.1392.

graphic

The QualityStocks
Company Corner

graphic
graphic

India Globalization Capital, Inc. (IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital, Inc. (NYSE: IGC). Today, India Globalization Capital, Inc. closed trading at $0.486, up 13.02%, on 279,793 volume with 755 trades. The stock’s average daily volume over the past 60 days is 392,900, and its 52-week low/high is $0.19/$0.80.

India Globalization Capital, Inc. (IGC) is a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.

The national cost of health care due to pain ranges from $560 billion to $635 billion. In addition, the health care cost attributed to the abuse of prescription opioids, closely related to pain, is approximately $25 billion. IGC's patent filing (IGC-501) is a cannabis-based formulation addressing neuropathic and arthritic pain in joints and muscles using a variety of delivery techniques. The Company anticipates commencing clinical trials, and hopes that through its focus on combination therapy it can formulate and commercialize cannabinoid compounds as an alternative to long-term addictive opioid treatments.

The Company has also filed combination therapy formulations for the treatment of epilepsy and cachexia. About 50 million people worldwide are affected by epilepsy and about 1.3 million in the U.S. experience cachexia associated with cancer, MS, Parkinson's, HIV/AIDS and other progressive illnesses. Cancer-induced anorexia/cachexia is responsible for 20% of all cancer deaths. IGC-502 indicated for seizures and IGC-504 indicated for cachexia are unique combination therapies that, if proven out by clinical trials, are expected to treat medical refractory epilepsy and eating disorders respectively, with lower side effects than conventional mono therapies.

IGC's strategy is exciting and unique in that it is aiming to become a leader in the phytocannabinoid-based combination therapy specialty pharmaceutical sector. This first mover advantage can potentially be formidable as it begins clinical trials and further builds its patent portfolio. "The development of combination therapies utilizing cannabis represents a large, unique opportunity in this emerging specialty-pharmaceutical sector. Securing FDA approval for combination therapy is believed to be significantly faster and less expensive than new drug applications. As a result, we believe that we can bring our cannabis-based pharmaceutical products to market in both an expeditious and cost-effective manner," stated Ram Mukunda, CEO.

IGC has recently exited its legacy businesses and currently holds international investments in land and in a hotel project. An impressive and experienced team, led by Mr. Ram Mukunda, CEO, directs IGC.

Mr. Mukunda holds degrees in Electrical Engineering and Mathematics from the University of Maryland (UMD). He founded and served as Chairman and CEO of Startec Global Communications, an international telecommunications carrier focused on providing voice over Internet protocol (VOIP) services to emerging economies. Startec, the first pure play international long distance carrier, went public on NASDAQ. He has won a number of awards, including the 2013 University of Maryland International Alumnus of the year award. Mr. Mukunda serves as an Emeritus member on the Board of Visitors at the University of Maryland, School of Engineering, and has served as Council Member at Harvard's Kennedy School of Government, Belfer Center of Science and International Affairs. Mr. Mukunda and Dr. Krishna are the originators of all the IGC patent filings.

Dr. Ranga Krishna, Senior Advisor, is a Board Certified Neurologist with a sub specialty in Epilepsy surgery. He is the Director of Neurology at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College and the Director of Stroke Service at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College. He is the Medical Director and Chairman of Total Neuro Care, P.C. He is CEO of International Pharma Trials, Inc., which assists U.S. pharmaceutical companies perform Phase II clinical trials. Dr. Krishna is a member of several organizations, including the American Academy of Neurology and the Medical Society of the State of New York. He is also a member of the Medical Arbitration panel for the New York State Workers' Compensation Board and a Founding Member of the New York State Pain Society. Dr. Krishna was trained at New York's Mount Sinai Medical Center (1991-1994) and New York University (1994-1996). Dr. Krishna and Mr. Mukunda are the originators of all the IGC patent filings. Disclaimer

India Globalization Capital, Inc. Company Blog

India Globalization Capital, Inc. News:

IGC Files International Patents for IGC-501 Compound Indicated for Neuropathic Pain

IGC Sells Malaysian Hotel Investment Interest, Consolidates Corporate Focus on Development of Cannabis-Based Combination Therapies

IGC Files Patent for Cannabis-based Combination Therapy for Treatment of Eating Disorders

National Waste Management Holdings, Inc. (NWMH)

The QualityStocks Daily Newsletter would like to spotlight National Waste Management Holdings, Inc. (NWMH). Today, National Waste Management Holdings, Inc. closed trading at $0.10, up 12.96%, on 2,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 19,235, and its 52-week low/high is $0.06/$0.41.

National Waste Management Holdings, Inc. (NWMH) is a solid waste management company offering comprehensive solutions for full waste diversion along Florida's west coast and in upstate New York. With an established base of long-term partnerships with municipal, institutional, commercial and industrial customers, along with a successful acquisition strategy, National Waste has set its course to become a leading waste diversion company.

National Waste's 54-acre landfill facility located in Hernando, Florida, handles annual average disposals of roughly 240,000 cubic yards of construction debris annually. The site also offers an array of ancillary services such as roll-off dumpster services, mulching services and recycling. While the landfill facility is already permitted for future expansion, National Waste's growth strategy also calls for the opening of new satellite offices in counties and states that neighbor its existing operations.

In addition to increasing its geographic foothold, National Waste employs a strategic acquisition model to increase its overall market share. In 2015, the company acquired Gateway Rolloff Services LP and Waste Recovery Enterprises LLC, which are expected to generate a combined $3.8 million in annual revenue for National Waste moving forward. In the second quarter of 2016, National Waste added Sivart Services to its roster, creating an immediate source of additional revenue and expanding its foothold in the northeast area of New York.

Management has confirmed its interest in additional acquisition targets while demonstrating its ability to effectively integrate and organically grow the company's existing acquisition companies and maintain efficient operations. Disclaimer

National Waste Management Holdings, Inc. Company Blog

National Waste Management Holdings, Inc. News:

National Waste Management Holdings Inc. Reports Full-Year 2016 Results, Triple-Digit Revenue Growth

National Waste Management Holdings, Inc. Expands Territory with Acquisition of Burts Refuse, LLC

National Waste Management Holdings, Inc. (NWMH) Expands Market Reach in New York with Acquisition of Northeast Data Destruction and Recycling

Bollente Companies, Inc. (BOLC)

The QualityStocks Daily Newsletter would like to spotlight Bollente Companies, Inc. (BOLC). Today, Bollente Companies, Inc. closed trading at $0.94, up 10.59%, on 2,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 7,352 and its 52-week low/high is $0.20/$1.00.

Bollente Companies, Inc. (BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Their current focus is on high-efficiency electric tankless water heaters, manufactured and sold under "trutankless", a division of Bollente, including a line of economy tankless water heaters sold under the Vero name. Units are available for both residential and commercial application.

The primary Bollente advantage is their use of advanced technology, superior to previous tankless systems, together with a growing U.S. and global market. Traditional water heaters are one of the costliest appliances to operate. The two primary energy sources used in U.S. homes are electric and natural gas, with less than half of U.S. homes having natural gas available. In addition, there are no significant electric whole home tankless manufacturers.

The U.S. Department of Energy now requires tanks of 55 gallons or more to have efficiency levels requiring expensive heat pumps to achieve. Bollente's trutankless electric tankless water heater employs specialized sensors for constant water temperature, solid state electronics, and proprietary software, resulting in one of the most efficient heat exchangers ever produced. The technology includes smart grid and home automation capabilities, remote control and monitoring, and even smartphone alerts. It also allows adjustable custom power management settings, so that users can further enhance energy usage and performance. It is now estimated that tankless heaters used in every home would save over $8 billion annually in the U.S. alone.

By maintaining 99 percent efficiency, Bollente's trutankless heaters use less energy than tank heaters, while providing the convenience of always-hot water. The system only uses power when there is demand, producing water to exact temperature, within one degree, even with sudden changes to input. Wireless apps allow for remote settings, notifications, and monitoring, and models are compatible with existing home automation and energy management systems. The technology also reduces size, for easy location, and the system's self-flushing design provides up to 20+ years of maintenance free operation, significantly reducing upkeep and replacement costs. This becomes an additional environmental benefit since roughly 8 million used water heaters are dumped in landfills every year.

Bollente has also announced the formation of Bollente International, Inc., a wholly-owned subsidiary, for the international production and sale of trutankless systems. Taking advantage of growing interest in their technology, Bollente International is working with an international manufacturing firm for the production and distribution of trutankless systems throughout Europe, Asia, Australia and New Zealand, with the first step being the testing and certification necessary to meet the various international standards.

Bollente has made electric tankless water heating compelling to a major consumer market, both in and outside the U.S., offering economic as well as operational efficiency and convenience, attractive to builders as well as to end consumers. Disclaimer

Bollente Companies, Inc. Blog

Bollente Companies, Inc. News:

Bollente Companies Increases Presence in Trending Segment of Commercial Construction with Its Smart trutankless Product Line

Award-Winning Luxury Builder Cullum Homes Makes trutankless® the Exclusive Water Heating Solution in its Communities

Bollente Companies, Inc. (BOLC) is “One to Watch”

GreenStone Healthcare Corp. (GRST)

The QualityStocks Daily Newsletter would like to spotlight GreenStone Healthcare Corp. (GRST). Today, GreenStone Healthcare Corp. closed trading at $0.04, even for the day. The stock’s average daily volume over the past 60 days is 68,101, and its 52-week low/high is $0.015/$0.083.

GreenStone Healthcare Corp. (GRST), through its subsidiaries, offers addiction and mental health rehabilitation treatments for residents, including out-patient counseling, coaching, intervention, psychological assessment, and other related services. The company recently sold its Canadian addiction treatment operations and acquired a U.S. based treatment center in Delray Beach, Florida, a major U.S. center for drug treatment programs located between Palm Beach and Miami. The company sought to expand into the U.S., where it could revolutionize treatment in that country with the skills it acquired in Canada. The company, through a subsidiary, will own and lease their assets in Canada, offering a stable secondary cash flow. Their newly acquired U.S. treatment center will be operated through a Florida limited liability company named Seastone Delray Healthcare LLC.

More than two thirds of families have been touched by a family member's addiction to alcohol, drugs, sex, and/or gambling. The addiction treatment market in the U.S. is estimated at over $35 billion annually, with a greater need than there are facilities. In addition, the GreeneStone approach differentiates itself in a number of ways:

  • Residents are treated holistically, taking into consideration all factors that can feed addiction, rather than the isolated treatment of addiction alone. Upon admission, all residents are fully assessed by professionals of a multidisciplinary team to develop an overall holistic treatment plan. An assembled team of best-in-class experts, including psychiatrists, physicians, nurses, and clinicians, manage and support residents who have co-occurring disorders such as depression, anxiety, and trauma.
  • Support is available both before and after resident treatment. Families can receive intervention support prior to admission, an often critical time for families and patients. Follow-up treatment support is available, to ensure progress and minimize the incidence of relapse. Families and others that are integral to the recovery are encouraged to participate in counseling and education sessions for continued success after in-patient treatment.

In addition to his experience with GreeneStone Healthcare, company president Shawn Leon has more than 25 years of experience managing public and private development-stage companies for various industries. He has provided financing and capital markets oversight for a number of these ventures, many of which have involved negotiations for mergers and acquisitions. Disclaimer

GreenStone Healthcare Corp. Company Blog

GreenStone Healthcare Corp. News:

GreeneStone Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida

GreeneStone Signs Definitive Agreement to Acquire Seastone of Delray, a Florida Limited Liability Company

GreeneStone Signs LOI to Acquire Aurora Recovery

ProBility Media Corp. (PBYA)

The QualityStocks Daily Newsletter would like to spotlight ProBility Media Corp. (PBYA). Today, ProBility Media Corp. closed trading at $0.474, even for the day. The stock’s average daily volume over the past 60 days is 2,642, and its 52-week low/high is $0.1205/$1.16.

ProBility Media Corp. (PBYA) based in Houston, TX, is an EdTech Company that is building the first full service training and career advancement brand for the skilled trades. Through both acquisitions and organic growth, ProBility is executing a disruptive strategy of defragmenting the market place of disparate companies servicing fifteen vertical categories in over sixty skilled trades. ProBility has positioned itself as a key industrial training resource for individuals, small- and medium-size businesses as well as enterprise customers offering consistent high-quality training services and materials for education, testing, and career advancement.

Through its Electrical Training Division, the company has become the biggest wholesaler of electrical codes and test preparation materials in the U.S., while its Construction Training Division is one of the largest certification providers in the country, with programs in 22 states, and continuing to grow. The company serves corporate accounts and government buyers, and also offers advisory services for companies of all sizes.

Companies currently under the ProBility Media conglomerate include:

  • Brown Technical Media Corp. – An online web business with multiple micro web sites featuring training materials and codes and standards sought by engineers, construction workers, scientists and other tradesmen in a wide variety of fields.
  • Brown Technical Publications – A proprietary publishing business generating copyrighted training materials for engineers, construction workers, scientists and other tradesman in a wide variety of fields.
  • 1ExamPrep – E-Learning, education and exam preparation for contractors via the cheapest, fastest and most effective exam prep school in the industry instituting our 4-point proven learning system.
  • National Electrical Wholesale Providers – In the business of distributing wholesale industrial, commercial and residential training materials including HVAC, plumbing and electrical.

ProBility's technology platform features virtual reality training for the crane business to be expanded into other industries, online subscription services for enterprise level companies, and recurring revenue streams. In addition, the company is already beginning to explore international expansion options, supported by the fact that other countries have adopted U.S. based codes, and have used U.S. training services.

The company's acquisition strategy targets operations that service engineering firms, electrical contractors, fabricators, plumbing contractors, pipe fitters, riggers, QC firms, and additional vocational industries. Disclaimer

ProBility Media Corp. Company Blog

ProBility Media Corp. News:

ProBility Media Corp. Appoints Billy Smith to the Newly Created Vocational Advisory Board

ProBility Media Corp. Files 10Q, Reports Third Consecutive Quarter of Revenue Growth

ProBility Media Corp. and GlobalSim Inc. Join Forces to Introduce Virtual Reality Training to the Crane Industry

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Penny Stock Titans
(DRSV) +113.78%

2.

StockMarketWatch
(SNGXW) +75.00%

3.

Profitable Trader Authority
(DCLT) +51.43%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251